AIP.NASDAQArteris, INC

Form 4: Arteris CEO Sells Shares Under Pre-Arranged 10b5-1 Plan

Sentiment:

Insider Transaction Report


Arteris, Inc. President and CEO, Janac K Charles, sold 17,884 shares of common stock for approximately $17.84 per share under a pre-arranged 10b5-1 trading plan.

Summary

  • Janac K Charles, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), reported a sale of common stock.
  • On January 15, 2026, Mr. Charles disposed of 17,884 shares of Arteris, Inc. common stock.
  • The shares were sold at a weighted average price of $17.8357 per share, with individual transaction prices ranging from $17.75 to $18.04.
  • This transaction was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Charles on March 5, 2025.
  • Following the reported transaction, Mr. Charles directly beneficially owns 139,487 shares of common stock.
  • Indirect beneficial ownership includes 9,399,071 shares held by Bayview Legacy, LLC, where Mr. Charles is the manager, and 56,252 shares held by the Charles and Lydia Janac Trust, for which Mr. Charles serves as trustee.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic trading, suggesting the sale is for personal financial management rather than a reflection of company performance.

Positives

  • The transaction was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate, non-public information, which enhances transparency and reduces concerns about opportunistic insider trading.

Negatives

  • An insider sale, even if pre-planned, reduces the direct equity stake of a key executive and director, which some investors might interpret as a signal, potentially impacting market sentiment.

Risks

  • The sale of shares by a high-ranking insider, even under a 10b5-1 plan, could be perceived negatively by the market, potentially leading to short-term downward pressure on the stock price due to investor sentiment regarding insider confidence.

Future Outlook

This Form 4 filing reports an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing reports a routine insider transaction under a pre-arranged trading plan and does not provide information directly related to broader industry trends or competitive landscape. Insider sales are common across industries for personal financial planning, diversification, or liquidity needs.

Related Party Transactions

  • Janac K Charles indirectly holds 9,399,071 shares through Bayview Legacy, LLC, where he is the manager and has voting and dispositive power.
  • Janac K Charles indirectly holds 56,252 shares through the Charles and Lydia Janac Trust, for which he serves as trustee.

Stakeholder Impact

  • Shareholders may observe the reduction in direct ownership by a key executive, potentially influencing their perception of management's confidence in the company, despite the 10b5-1 plan.

Key Dates

DateDescription
03/05/2025Date the 10b5-1 trading plan was adopted by Janac K Charles.
01/15/2026Date of the reported transaction (sale of common stock).
01/20/2026Date the Form 4 filing was signed and submitted.

Keywords

Arteris, AIP, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, CEO, Director, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.